[ad_1]
Drug
Pharmacologic Class
Indication
Extra Info
Neurologic Issues
Daybue (trofinetide)
Artificial analogue of glycine-proline-glutamate
Remedy of Rett syndrome in adults and pediatric sufferers 2 years of age and older.
FDA Greenlights Daybue for Remedy of Rett Syndrome
Oncology
Verzenio (abemaciclib)
Kinase inhibitor
Together with endocrine remedy (tamoxifen or an aromatase inhibitor), for the adjuvant therapy of adults with hormone receptor-positive, human epidermal progress issue receptor 2-negative, node-positive, early breast most cancers at excessive threat of recurrence.
Verzenio Drug Monograph
Tafinlar (dabrafenib) + Mekinist (trametinib)
Kinase inhibitors
Remedy of pediatric sufferers 1 yr of age and older with low-grade glioma with a BRAF V600E mutation who require systemic remedy.
Tafinlar + Mekinist Authorised for Pediatric BRAF V600E Low-Grade Glioma
Zynyz (retifanlimab-dlwr)
Programmed dying receptor-1-blocking antibody
Remedy of adults with metastatic or recurrent regionally superior Merkel cell carcinoma.
Zynyz Authorised for Metastatic or Recurrent Domestically Superior Merkel Cell Carcinoma
Ache Administration
Zavzpret (zavegepant)
Calcitonin gene-related peptide receptor antagonist
Remedy of migraine with or with out aura in adults.
Zavzpret Nasal Spray Authorised for Acute Remedy of Migraine
Immune Issues
Joenja (leniolisib)
Selective PI3Kδ inhibitor
Remedy of activated phosphoinositide 3-kinase delta syndrome in sufferers 12 years of age and older.
Joenja Authorised for Activated Phosphoinositide 3-Kinase Delta Syndrome
Infectious Illness
Rezzayo (rezafungin for injection)
Echinocandin antifungal
Remedy of candidemia and invasive candidiasis in adults with restricted or no different therapy choices.
FDA Approves Antifungal Rezzayo for Sufferers With Restricted Remedy Choices
[ad_2]
Source link